SAN DIEGO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Icosavax, Inc. (NASDAQ:ICVX) breached their fiduciary duties in connection with the proposed sale of the Company to AstraZeneca.
You can click or copy and paste the following link to join this investigation:
https://www.johnsonfistel.com/investigations/Icosavax-co
On November 30, 2023, Icosavax announced that it had entered a deal to merge with AstraZeneca. Under the terms of the deal, Icosavax shareholders will receive $15.00 per share in cash at closing, plus a ...